302 related articles for article (PubMed ID: 27143302)
1. Core 1- and 3-derived O-glycans collectively maintain the colonic mucus barrier and protect against spontaneous colitis in mice.
Bergstrom K; Fu J; Johansson ME; Liu X; Gao N; Wu Q; Song J; McDaniel JM; McGee S; Chen W; Braun J; Hansson GC; Xia L
Mucosal Immunol; 2017 Jan; 10(1):91-103. PubMed ID: 27143302
[TBL] [Abstract][Full Text] [Related]
2. Defective Intestinal Mucin-Type O-Glycosylation Causes Spontaneous Colitis-Associated Cancer in Mice.
Bergstrom K; Liu X; Zhao Y; Gao N; Wu Q; Song K; Cui Y; Li Y; McDaniel JM; McGee S; Chen W; Huycke MM; Houchen CW; Zenewicz LA; West CM; Chen H; Braun J; Fu J; Xia L
Gastroenterology; 2016 Jul; 151(1):152-164.e11. PubMed ID: 27059389
[TBL] [Abstract][Full Text] [Related]
3. Loss of intestinal O-glycans promotes spontaneous duodenal tumors.
Gao N; Bergstrom K; Fu J; Xie B; Chen W; Xia L
Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G74-83. PubMed ID: 27229122
[TBL] [Abstract][Full Text] [Related]
4. Core 3-derived O-glycans are essential for intestinal mucus barrier function.
Xia L
Methods Enzymol; 2010; 479():123-41. PubMed ID: 20816163
[TBL] [Abstract][Full Text] [Related]
5. Increased susceptibility to colitis and colorectal tumors in mice lacking core 3-derived O-glycans.
An G; Wei B; Xia B; McDaniel JM; Ju T; Cummings RD; Braun J; Xia L
J Exp Med; 2007 Jun; 204(6):1417-29. PubMed ID: 17517967
[TBL] [Abstract][Full Text] [Related]
6. Loss of intestinal core 1-derived O-glycans causes spontaneous colitis in mice.
Fu J; Wei B; Wen T; Johansson ME; Liu X; Bradford E; Thomsson KA; McGee S; Mansour L; Tong M; McDaniel JM; Sferra TJ; Turner JR; Chen H; Hansson GC; Braun J; Xia L
J Clin Invest; 2011 Apr; 121(4):1657-66. PubMed ID: 21383503
[TBL] [Abstract][Full Text] [Related]
7. Detailed O-glycomics of the Muc2 mucin from colon of wild-type, core 1- and core 3-transferase-deficient mice highlights differences compared with human MUC2.
Thomsson KA; Holmén-Larsson JM; Angström J; Johansson ME; Xia L; Hansson GC
Glycobiology; 2012 Aug; 22(8):1128-39. PubMed ID: 22581805
[TBL] [Abstract][Full Text] [Related]
8. Age-Related Mucus Barrier Dysfunction in Mice Is Related to the Changes in Muc2 Mucin in the Colon.
Sang X; Wang Q; Ning Y; Wang H; Zhang R; Li Y; Fang B; Lv C; Zhang Y; Wang X; Ren F
Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111049
[TBL] [Abstract][Full Text] [Related]
9. Altered mucus glycosylation in core 1 O-glycan-deficient mice affects microbiota composition and intestinal architecture.
Sommer F; Adam N; Johansson ME; Xia L; Hansson GC; Bäckhed F
PLoS One; 2014; 9(1):e85254. PubMed ID: 24416370
[TBL] [Abstract][Full Text] [Related]
10. Muc2 mucin O-glycosylation interacts with enteropathogenic Escherichia coli to influence the development of ulcerative colitis based on the NF-kB signaling pathway.
Wei J; Chen C; Feng J; Zhou S; Feng X; Yang Z; Lu H; Tao H; Li L; Xv H; Xuan J; Wang F
J Transl Med; 2023 Nov; 21(1):793. PubMed ID: 37940996
[TBL] [Abstract][Full Text] [Related]
11. Studies of mucus in mouse stomach, small intestine, and colon. III. Gastrointestinal Muc5ac and Muc2 mucin O-glycan patterns reveal a regiospecific distribution.
Holmén Larsson JM; Thomsson KA; Rodríguez-Piñeiro AM; Karlsson H; Hansson GC
Am J Physiol Gastrointest Liver Physiol; 2013 Sep; 305(5):G357-63. PubMed ID: 23832516
[TBL] [Abstract][Full Text] [Related]
12. The mucin Muc2 limits pathogen burdens and epithelial barrier dysfunction during Salmonella enterica serovar Typhimurium colitis.
Zarepour M; Bhullar K; Montero M; Ma C; Huang T; Velcich A; Xia L; Vallance BA
Infect Immun; 2013 Oct; 81(10):3672-83. PubMed ID: 23876803
[TBL] [Abstract][Full Text] [Related]
13. Elevated miR-124-3p in the aging colon disrupts mucus barrier and increases susceptibility to colitis by targeting T-synthase.
Huang L; Sun TY; Hu LJ; Hu SL; Sun HM; Zhao FQ; Wu B; Yang S; Ji FQ; Zhou DS
Aging Cell; 2020 Nov; 19(11):e13252. PubMed ID: 33040455
[TBL] [Abstract][Full Text] [Related]
14. Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis.
Johansson ME; Gustafsson JK; Holmén-Larsson J; Jabbar KS; Xia L; Xu H; Ghishan FK; Carvalho FA; Gewirtz AT; Sjövall H; Hansson GC
Gut; 2014 Feb; 63(2):281-91. PubMed ID: 23426893
[TBL] [Abstract][Full Text] [Related]
15. Mucin-type O-glycans and their roles in intestinal homeostasis.
Bergstrom KS; Xia L
Glycobiology; 2013 Sep; 23(9):1026-37. PubMed ID: 23752712
[TBL] [Abstract][Full Text] [Related]
16. Microbial, metabolomic, and immunologic dynamics in a relapsing genetic mouse model of colitis induced by T-synthase deficiency.
Jacobs JP; Lin L; Goudarzi M; Ruegger P; McGovern DP; Fornace AJ; Borneman J; Xia L; Braun J
Gut Microbes; 2017 Jan; 8(1):1-16. PubMed ID: 27874308
[TBL] [Abstract][Full Text] [Related]
17. Loss of mucin-type
Song K; Fu J; Song J; Herzog BH; Bergstrom K; Kondo Y; McDaniel JM; McGee S; Silasi-Mansat R; Lupu F; Chen H; Bagavant H; Xia L
J Biol Chem; 2017 Oct; 292(40):16491-16497. PubMed ID: 28842487
[TBL] [Abstract][Full Text] [Related]
18. IL-22 promotes mucin-type O-glycosylation and MATH1
Singh A; Beaupre M; Villegas-Novoa C; Shiomitsu K; Gaudino SJ; Tawch S; Damle R; Kempen C; Choudhury B; McAleer JP; Sheridan BS; Denoya P; Blumberg RS; Hearing P; Allbritton NL; Kumar P
Cell Rep; 2024 May; 43(5):114206. PubMed ID: 38733584
[TBL] [Abstract][Full Text] [Related]
19. Roles of the gel-forming MUC2 mucin and its O-glycosylation in the protection against colitis and colorectal cancer.
Kawashima H
Biol Pharm Bull; 2012; 35(10):1637-41. PubMed ID: 23037153
[TBL] [Abstract][Full Text] [Related]
20. Global Loss of Core 1-Derived
Suzuki R; Nakamura Y; Koiwai R; Fuseya S; Murakami Y; Hagiwara K; Sato T; Takahashi S; Kudo T
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
